Leeward Financial Partners’s AbbVie ABBV Stock Holding History

Leeward Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Buy	1,271 +3	+0.2%	+$645	0.08%	88
2026 Q1	$276K	Hold	1,268	–	–	0.08%	90
2025 Q4	$290K	Sell	1,268 -28	-2%	-$6.38K	0.08%	88
2025 Q3	$300K	Sell	1,296 -18	-1%	-$3.67K	0.09%	88
2025 Q2	$244K	Buy	+1,314	New	+$244K	0.08%	95
2023 Q3	–	Sell	-2,239	Closed	-$302K	–	77
2023 Q2	$302K	Sell	2,239 -16,692	-88%	-$2.45M	0.17%	66
2023 Q1	$3.02M	Buy	18,931 +1,113	+6%	+$170K	1.85%	18
2022 Q4	$2.88M	Buy	17,818 +476	+3%	+$73K	1.99%	17
2022 Q3	$2.33M	Buy	17,342 +573	+3%	+$82.2K	1.67%	22
2022 Q2	$2.57M	Buy	+16,769	New	+$2.56M	1.76%	21

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leeward Financial Partners's ABBV Position: Q2 2026 in Review

Leeward Financial Partners increased its AbbVie (ABBV) stake by 0.24% in Q2 2026, buying an estimated $645 and bringing the position to 1,271 shares worth $320K. The position accounts for 0.08% of the portfolio, ranked #88.

Leeward Financial Partners first reported a position in ABBV in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.02M in Q1 2023. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Leeward Financial Partners held 1,271 shares of AbbVie worth $320K as of Q2 2026.
Leeward Financial Partners bought 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.08% of Leeward Financial Partners's portfolio in Q2 2026, its #88 holding.
Leeward Financial Partners first reported a position in AbbVie in Q2 2022 and has held it in 10 quarters since.
Leeward Financial Partners's AbbVie position peaked at $3.02M in Q1 2023.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leeward Financial Partners's 13F filing for Q2 2026, filed 6 Aug 2026.